Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
Cisco Extends Growth Streak on Strong Software Sales - WSJ

7m wsj
Cisco Systems Inc. on Wednesday reported its third-consecutive quarter of revenue growth, evidence the networking-gear maker’s move to build up its software business is paying off.
CSCO

2
Cisco Systems Stock Surges on Q4 Earnings, Revenue Beat

47m investorplace
Cisco Systems (NASDAQ:CSCO) ended hump day on a high note as the company reported its latest quarterly earnings results, which topped what analysts were calling for in their consensus estimate.
CSCO TRI

2
Cisco gives bullish outlook helped by new products, software

47m sfgate
Cisco Systems gave a bullish forecast for the current quarter, boosted by corporate spending on upgrades to computer networks.
CSCO

2
CACI International (CACI) Surpasses Q4 Earnings Estimates

1h zacks
CACI International (CACI - Free Report) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.76 per share a year ago. These figures are adjusted for non-recurring items.
PLNT POETF NAT CACU CACI PTK CSCO

2
Briggs & Stratton (BGG) Q4 Earnings and Revenues Top Estimates

1h zacks
Briggs & Stratton (BGG - Free Report) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.46 per share a year ago. These figures are adjusted for non-recurring items.
PLNT POETF BGG NAT PTK CSCO

2
Cisco Systems (CSCO) Q4 Earnings and Revenues Top Estimates

1h zacks
Cisco Systems (CSCO - Free Report) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.61 per share a year ago. These figures are adjusted for non-recurring items.
PLNT POETF NAT PTK CSCO

2
Cisco tops revenue estimates as newer bets pay off

3h reuters
(Reuters) - Cisco Systems Inc (CSCO.O) reported quarterly revenue above Wall Street estimates on Wednesday, driven by growth in the network gear maker’s newer businesses such as cyber security.
CSCO

2
Cisco shares rise after earnings, outlook beat Street - MarketWatch

3h marketwatch
Cisco Systems Inc. CSCO, -0.32% shares rose in the extended session Wednesday after the network equipment and services company's earnings and outlook topped Wall Street estimates. Cisco shares advanced 3.2% after hours, following a 0.3% decline to close at $43.86 in the regular session. The company reported fiscal fourth-quarter net income of $3.8 billion, or 81 cents a share, compared with $2.42 billion, or 48 cents a share, in the year-ago period.
CSCO

2
Cisco Reports Fourth Quarter and Fiscal Year 2018 Earnings

3h globenewswire
SAN JOSE, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Cisco today reported fourth quarter and fiscal year results for the period ended July 28, 2018. Cisco reported fourth quarter revenue of $12.8 billion, net income on a generally accepted accounting principles (GAAP) basis of $3.8 billion or $0.81 per share, and non-GAAP net income of $3.3 billion or $0.70 per share.
ANET CSCO

2
CSCO / Cisco Systems, Inc. FORM 8-K (Current Report)

3h sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CSCO

2
What to Look For in Cisco’s Earnings Report

9h 247wallst
Cisco Systems Inc. (NASDAQ: CSCO) has been one of the top Dow Jones industrials stocks for most of 2018 so far, and while this momentum has been impressive, earnings need to be equally — or even more — impressive to keep investors satisfied. While Cisco did top estimates in its previous quarter, it didn’t seem to be enough for investors at the time.
CSCO TRI

16
Wall Street in cautious mode with eye on Turkey

12h cnbc
Futures were lower this morning as investors focused on the ongoing situation in Turkey. The Dow and S&P 500 had their first gains in five sessions yesterday, with the Nasdaq higher for the first time in three days. (CNBC) * Turkey slashes capacity of banks to bet against struggling lira (CNBC)
BRK.A LMT STZ.B CSCO STZ BLUE ONCE FANG

2
Cisco Earnings Preview: A Dip Could Be a Buying Opportunity

12h investorplace
Multinational technology giant Cisco (NASDAQ:CSCO) reports fourth-quarter numbers after the bell on Wednesday, August 15, and I think those numbers could very well meet and/or exceed expectations. But, CSCO stock is trading at an above-normal valuation heading into that report, and as such, management will need to give a robust guide in order to send CSCO stock higher. The chances of that happening are mixed, so the risk-reward on CSCO stock ahead of earnings isn’t great.
CSCO

2
US markets: investors switch focus to earnings; Turkey crisis weighs

14h cnbc
U.S. stock index futures came under pressure ahead of Wednesday's open, as investors awaited fresh corporate earnings from major U.S. companies.
CSCO PSHZF

63
More Dow Gains Ahead For Caterpillar, DowDuPont, Goldman, Chevron, And Boeing Per Broker August 1-Year Estimates

16h seekingalpha
"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration".
PG CAT XOM VZA GS GLSSP CSCO KO INTC MCD IBM JBK GSC TFG UTX DWDP GSJ JNJ MRK CVX VZ BA GJS PFE

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 17275R102